Pure Global
NCT05777473

Tipping Point: Using Social Network Theory to Accelerate Scale and Impact

University of California, San Diego·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Contraception
Drug/Device/Intervention
Household Visits
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of California, San Diego
Location
San Diego, United States of America
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2020
End date
May 01, 2025
Enrollment
3825 participants
Primary outcome

Contraception Use Questionnaire (individual items, not a scale),Intentions To Use Contraception Questionnaire (individual items, not a scale)

Summary

This study will assess the nature and impact of social norms and networks to promote FP
 (Family Planning) intervention effects among low parity, married adolescent and young women
 in the Maradi region of Niger. Research activities will be layered on top of the USAID-funded
 Kulawa FP program that seeks to change FP-related behaviors among young, low parity women at
 scale in Niger in a subset of implementing villages. Kulawa, implemented by Save the Children
 U.S. (SCUS) and funded by USAID (2020-2025), will include small-group discussion for young,
 low parity girls coupled with community dialogues to address individual, social, and health
 system constraints to FP use and influence social norms that govern FP use. UCSD will not
 provide any services or implement any interventions as part of this study.

ICD-10 classifications
Contraceptive managementOral contraceptivesOther contraceptive managementGeneral counselling and advice on contraceptionPersonal history of contraception
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05777473
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05777473 through Pure Global AI's free database. This phase not specified trial is sponsored by University of California, San Diego and is currently Not yet recruiting. The study focuses on Contraception. Target enrollment is 3825 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.